1. Home
  2. FSUN vs LQDA Comparison

FSUN vs LQDA Comparison

Compare FSUN & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSUN
  • LQDA
  • Stock Information
  • Founded
  • FSUN 1892
  • LQDA 2004
  • Country
  • FSUN United States
  • LQDA United States
  • Employees
  • FSUN N/A
  • LQDA N/A
  • Industry
  • FSUN Major Banks
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSUN Finance
  • LQDA Health Care
  • Exchange
  • FSUN Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • FSUN 1.1B
  • LQDA 957.2M
  • IPO Year
  • FSUN N/A
  • LQDA 2018
  • Fundamental
  • Price
  • FSUN $40.03
  • LQDA $11.10
  • Analyst Decision
  • FSUN Hold
  • LQDA Strong Buy
  • Analyst Count
  • FSUN 1
  • LQDA 8
  • Target Price
  • FSUN N/A
  • LQDA $27.14
  • AVG Volume (30 Days)
  • FSUN 99.2K
  • LQDA 930.6K
  • Earning Date
  • FSUN 01-01-0001
  • LQDA 11-13-2024
  • Dividend Yield
  • FSUN N/A
  • LQDA N/A
  • EPS Growth
  • FSUN N/A
  • LQDA N/A
  • EPS
  • FSUN 3.05
  • LQDA N/A
  • Revenue
  • FSUN $348,035,000.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • FSUN N/A
  • LQDA N/A
  • Revenue Next Year
  • FSUN $80.04
  • LQDA $209.63
  • P/E Ratio
  • FSUN $13.11
  • LQDA N/A
  • Revenue Growth
  • FSUN N/A
  • LQDA N/A
  • 52 Week Low
  • FSUN $33.00
  • LQDA $8.26
  • 52 Week High
  • FSUN $44.37
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • FSUN 52.59
  • LQDA 52.98
  • Support Level
  • FSUN $37.15
  • LQDA $10.37
  • Resistance Level
  • FSUN $40.80
  • LQDA $11.44
  • Average True Range (ATR)
  • FSUN 2.53
  • LQDA 0.54
  • MACD
  • FSUN -0.22
  • LQDA -0.03
  • Stochastic Oscillator
  • FSUN 40.22
  • LQDA 51.41

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company for Sunflower Bank, National Association. It provides a full range of deposit, lending, treasury management, wealth management and online banking products and services. The company operates in two segments - Banking operations and Mortgage operations, out of which the majority of the revenue is generated from the Banking operations segment.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: